Evidence map›Paper›PMID 17310990›Full record

ArticleOncogene2007

Human INT6 interacts with MCM7 and regulates its stability during S phase of the cell cycle.

S Buchsbaum, C Morris, V Bochard, P Jalinot

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

S BuchsbaumLaboratoire de Biologie Moléculaire de la Cellule, UMR5161 CNRS/ENS de Lyon, IFR 128 Biosciences Lyon Gerland, Lyon cedex 07, Rhone, France.
C Morris
V Bochard
P Jalinot
École Normale Supérieure de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mouse int6 gene is a frequent integration site of the mouse mammary tumor virus and INT6 silencing by RNA interference in HeLa cells causes an increased number of cells in the G2/M phases of the cell cycle, along with mitotic defects. In this report, we investigated the functional significance of the interaction between INT6 and MCM7, which was observed in a two-hybrid screen performed with INT6 as bait. It was found that proteasome inhibition strengthens interaction between both proteins and that INT6 stabilizes MCM7. Removal of MCM7 from chromatin as replication proceeds was accelerated in INT6-silenced cells and reduced amounts of protein were transiently observed, followed by a correction resulting from stimulation of mcm7 gene expression. Synchronized cells depleted for either INT6 or MCM7 display a reduction in thymidine incorporation and a reinforced association of RPA and claspin with chromatin. These data show that INT6 stabilizes chromatin-bound MCM7 and that alteration of this effect is associated with replication deficiency.

Indexed as

DNA ReplicationAdaptor Proteins, Signal TransducingCell CycleCell Cycle ProteinsChromatinDNA-Binding ProteinsEukaryotic Initiation Factor-3Genome, HumanHeLa CellsHumansJurkat CellsMinichromosome Maintenance Complex Component 7Nuclear ProteinsPolyubiquitinProteasome InhibitorsS PhaseAdaptor Proteins, Signal TransducingCell Cycle ProteinsChromatinCLSPN protein, humanDNA-Binding ProteinsEukaryotic Initiation Factor-3MCM7 protein, humanMinichromosome Maintenance Complex Component 7Nuclear ProteinsPolyubiquitinProteasome Inhibitors

Identifiers

PMID17310990
OpenAlexW1988872192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.